Roche Holding

Roche Position1 on Similar Biotherapeutic Products – Biosimilars
Similar Biotherapeutic Products – Biosimilars
Over the past years, an increasing number of innovative biotherapeutic products (e.g. monoclonal
antibodies) have lost market exclusivity, and products claimed to be similar to an innovative product
have been and are being developed and commercialised.
While it is relatively easy to copy small molecule products produced by chemical synthesis, it is very
challenging to copy...